Literature DB >> 18559929

Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation.

Dajana Paulmann1, Thomas Magulski1, Rebecca Schwarz1, Lisa Heitmann1, Bertram Flehmig2, Angelika Vallbracht1, Andreas Dotzauer1.   

Abstract

Hepatitis A virus (HAV) antagonizes the innate immune response by inhibition of retinoic acid-inducible gene I-mediated and melanoma differentiation-associated gene 5-mediated beta interferon (IFN-beta) gene expression. This study showed that this is due to an interaction of HAV with mitochondrial antiviral signalling protein (MAVS)-dependent signalling, in which the viral non-structural protein 2B and the protein intermediate 3ABC recently suggested in this context seem to be involved, cooperatively affecting the activities of MAVS and the kinases TANK-binding kinase 1 (TBK1) and the inhibitor of NF-kappaB kinase epsilon (IKKepsilon). In consequence, interferon regulatory factor 3 (IRF-3) is not activated. As IRF-3 is necessary for IFN-beta transcription, inhibition of this factor results in efficient suppression of IFN-beta synthesis. This ability might be of vital importance for HAV, which is an exceptionally slow growing virus sensitive to IFN-beta, as it allows the virus to establish infection and maintain virus replication for a longer period of time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559929     DOI: 10.1099/vir.0.83521-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

2.  Structural basis for host membrane remodeling induced by protein 2B of hepatitis A virus.

Authors:  Laia Vives-Adrián; Damià Garriga; Mònica Buxaderas; Joana Fraga; Pedro José Barbosa Pereira; Sandra Macedo-Ribeiro; Núria Verdaguer
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon.

Authors:  Manish Kumar; Sung Yun Jung; Amanda J Hodgson; Charles R Madden; Jun Qin; Betty L Slagle
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

4.  Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.

Authors:  Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Müller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Journal:  Virol J       Date:  2010-09-03       Impact factor: 4.099

5.  Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses.

Authors:  Iwona A Buskiewicz; Andreas Koenig; Sally A Huber; Ralph C Budd
Journal:  Future Virol       Date:  2012-12       Impact factor: 1.831

Review 6.  Viral tricks to grid-lock the type I interferon system.

Authors:  Gijs A Versteeg; Adolfo García-Sastre
Journal:  Curr Opin Microbiol       Date:  2010-06-10       Impact factor: 7.934

7.  Convergent evolution of escape from hepaciviral antagonism in primates.

Authors:  Maulik R Patel; Yueh-Ming Loo; Stacy M Horner; Michael Gale; Harmit S Malik
Journal:  PLoS Biol       Date:  2012-03-13       Impact factor: 8.029

Review 8.  Mechanisms underlying the inhibition of interferon signaling by viruses.

Authors:  Anand S Devasthanam
Journal:  Virulence       Date:  2014-02-06       Impact factor: 5.882

9.  Identification and validation of a novel microRNA-like molecule derived from a cytoplasmic RNA virus antigenome by bioinformatics and experimental approaches.

Authors:  Jiandong Shi; Zhiqing Duan; Jing Sun; Meini Wu; Bin Wang; Jing Zhang; Haixuan Wang; Ningzhu Hu; Yunzhang Hu
Journal:  Virol J       Date:  2014-07-01       Impact factor: 4.099

Review 10.  Viral and host proteins involved in picornavirus life cycle.

Authors:  Jing-Yi Lin; Tzu-Chun Chen; Kuo-Feng Weng; Shih-Cheng Chang; Li-Lien Chen; Shin-Ru Shih
Journal:  J Biomed Sci       Date:  2009-11-20       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.